Join our webinar for insights into how our CRO and CPU approach patient studies, our unique collaboration with external specialists and more.
Overview
We will discuss how our contract research organization (CRO) and clinical pharmacology unit (CPU) approach patient studies, focusing on our unique collaboration with external specialists and how this allows us to build an esteemed network. A testimonial from Dr. De Volder of University Hospital Antwerp (UZA) will further illustrate this collaborative approach. Additionally, we will discuss our hybrid studies approach, which allows for swift proof of concept of drug efficacy.
Objective
The objective of this webinar is to showcase how businesses can benefit from our streamlined operations and hybrid study approach, as well as how we alleviate specalists' administrative burdens, allowing them to focus on patient care. Additionally, you will hear, firsthand, about the experience of collaboration with SGS, from specialist Dr. De Volder.
Agenda
- Insights into hybrid study design
- SGS's CRO and CPU operations in building a network of specialists to support clinical studies conducted by SGS
- Involvement of specialists in early phase patient trials
- Testimonial from Dr. De Volder of UZA
- Q&A session: engage with experts, clarify your concerns
Target Audience: The webinar is aimed at all pharmaceutical and biotech professionals, as well as esteemed clinicians.
Language: English
Can't make a live session? Register now and receive a complimentary recording after the live event.